Heartflow, Inc. (NASDAQ:HTFL) Receives $37.67 Consensus PT from Analysts

Shares of Heartflow, Inc. (NASDAQ:HTFL) have been assigned an average recommendation of “Moderate Buy” from the nine ratings firms that are presently covering the stock, MarketBeat reports. One investment analyst has rated the stock with a sell recommendation, two have given a hold recommendation and six have assigned a buy recommendation to the company. The average 12-month price objective among analysts that have issued a report on the stock in the last year is $37.6667.

Several research analysts have weighed in on the stock. Wells Fargo & Company lowered their target price on shares of Heartflow from $38.00 to $35.00 and set an “overweight” rating for the company in a research note on Thursday, March 19th. Canaccord Genuity Group increased their target price on shares of Heartflow from $40.00 to $43.00 and gave the stock a “buy” rating in a research note on Thursday, March 19th. William Blair assumed coverage on shares of Heartflow in a research note on Monday, May 4th. They set an “outperform” rating for the company. Finally, JPMorgan Chase & Co. lowered their target price on shares of Heartflow from $40.00 to $35.00 and set an “overweight” rating for the company in a research note on Thursday, March 19th.

Heartflow Trading Up 3.3%

Shares of HTFL opened at $32.24 on Friday. Heartflow has a 12-month low of $20.13 and a 12-month high of $41.22. The firm has a 50-day moving average price of $27.19 and a 200 day moving average price of $28.87. The firm has a market capitalization of $2.78 billion and a P/E ratio of -16.20.

Heartflow (NASDAQ:HTFL) last announced its quarterly earnings data on Thursday, May 14th. The company reported ($0.16) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.24) by $0.08. The firm had revenue of $52.59 million during the quarter. The firm’s revenue for the quarter was up 41.3% on a year-over-year basis. Equities research analysts predict that Heartflow will post -0.78 earnings per share for the current fiscal year.

Insider Buying and Selling at Heartflow

In other news, CEO John C.M. Farquhar sold 22,562 shares of the firm’s stock in a transaction that occurred on Monday, May 11th. The shares were sold at an average price of $29.12, for a total value of $657,005.44. Following the completion of the transaction, the chief executive officer owned 519,397 shares of the company’s stock, valued at approximately $15,124,840.64. This trade represents a 4.16% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Campbell Rogers sold 64,533 shares of the firm’s stock in a transaction that occurred on Wednesday, April 1st. The shares were sold at an average price of $24.64, for a total transaction of $1,590,093.12. Following the completion of the sale, the insider directly owned 81,002 shares in the company, valued at approximately $1,995,889.28. This trade represents a 44.34% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last three months, insiders sold 2,205,874 shares of company stock worth $64,166,729. 7.70% of the stock is owned by company insiders.

Hedge Funds Weigh In On Heartflow

Several hedge funds have recently added to or reduced their stakes in the stock. TrueMark Investments LLC increased its stake in Heartflow by 1.4% in the first quarter. TrueMark Investments LLC now owns 26,885 shares of the company’s stock valued at $654,000 after purchasing an additional 379 shares during the last quarter. Caitong International Asset Management Co. Ltd purchased a new position in Heartflow in the fourth quarter valued at approximately $27,000. TFC Financial Management Inc. purchased a new position in Heartflow in the third quarter valued at approximately $40,000. Strs Ohio increased its stake in Heartflow by 35.3% in the first quarter. Strs Ohio now owns 4,600 shares of the company’s stock valued at $112,000 after purchasing an additional 1,200 shares during the last quarter. Finally, Russell Investments Group Ltd. purchased a new position in Heartflow in the fourth quarter valued at approximately $45,000.

About Heartflow

HeartFlow, Inc (NASDAQ: HTFL) is a medical technology company that develops non-invasive diagnostic solutions for coronary artery disease. The company’s core offering translates coronary CT angiography (CTA) data into a patient-specific, three-dimensional physiological model of the coronary arteries. Using advanced image processing and computational modeling, HeartFlow’s analysis estimates fractional flow reserve (FFR) values throughout the coronary tree to identify ischemia-producing lesions without the need for invasive pressure-wire measurements.

HeartFlow’s cloud-based service integrates with clinical workflows: clinicians submit coronary CTA images and receive a detailed, color-coded 3D map and report that highlights lesion-specific FFR values and physiological impact.